GlassScriptPhysician profile
Sandip Desai
NPI 1497741037
$17,601.44
in general payments reported to CMS, 2019-2025
50 companies · $4,350 in 2025
The $4,350 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,430 · 2020: $1,798 · 2021: $2,069 · 2022: $2,063 · 2023: $2,404 · 2024: $2,487 · 2025: $4,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,241.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,634.68 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $2,692.00 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $1,798.70 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,358.39 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $1,326.91 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $973.59 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Electromed, INC. | $797.51 | 2019-2025 | Smartvest |
| Mylan Specialty L.P. | $575.11 | 2019-2024 | Yupelri, Yupelri |
| Insmed, INC. | $423.78 | 2021-2025 | Arikayce |
| Mallinckrodt Hospital Products INC. | $387.77 | 2020-2025 | Acthar |
| Abbott Laboratories | $371.52 | 2022-2024 | Cardiomems |
| Amgen INC. | $328.05 | 2022-2025 | Tezspire |
| Genentech USA, INC. | $269.68 | 2019 | |
| United Therapeutics Corporation | $244.36 | 2020-2022 | |
| Abbvie INC. | $229.84 | 2021-2025 | Avycaz |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $156.59 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $150.58 | 2021-2023 | Austedo Xr, Airduo Digihaler |
| Verona Pharma, INC. | $140.97 | 2025 | Ohtuvayre |
| Abiomed | $140.07 | 2025 | |
| Edwards Lifesciences Corporation | $118.35 | 2019 | |
| Merck Sharp & Dohme LLC | $112.94 | 2021-2025 | Winrevair |
| Novo Nordisk INC | $102.66 | 2022 | |
| Sunovion Pharmaceuticals INC. | $99.70 | 2019 | |
| Boston Scientific Corporation | $94.64 | 2019 | |
| Philips North America LLC | $90.53 | 2019-2020 | |
| Allergan, INC. | $89.37 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $80.57 | 2025 | Neffy |
| Circassia INC. | $66.35 | 2019-2020 | |
| Pfizer INC. | $66.07 | 2019-2025 | |
| Grifols USA, LLC | $62.41 | 2022 | |
| Shionogi INC | $60.62 | 2021 | |
| Inogen, INC. | $58.95 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novartis Pharmaceuticals Corporation | $54.97 | 2025 | |
| Vanda Pharmaceuticals INC. | $51.76 | 2019-2020 | |
| Viatris Specialty LLC | $51.51 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $42.54 | 2022-2025 | Purified Cortrophin Gel |
| Pulmonx Corporation | $40.92 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Sanofi US Services INC. | $31.71 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.07 | 2025 | |
| Mayne Pharma Commercial LLC | $23.76 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.52 | 2020 | |
| Paratek Pharmaceuticals, INC. | $23.26 | 2021 | |
| 3b Medical, INC. | $21.40 | 2025 | Luna |
| Organogenesis INC. | $19.04 | 2020 | |
| Phadia US INC. | $16.05 | 2023 | Immunocap |
| Medtronic Vascular, INC. | $15.84 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.01 | 2022 | |
| Covis Pharma Gmbh | $13.31 | 2022 | |
| Harmony Biosciences LLC | $13.03 | 2022 | |
| Astellas Pharma US INC | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandip Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.